Castleman disease (CD) is a rare group of heterogeneous lymphoproliferative disorders, many of which have an unknown underlying etiology. Owing to its rarity and unknown etiology, many oncology nurses are unaware of this disease, despite it often being managed by hematology/oncology clinics. As a result, this webinar aims to further educate on the diagnosis and treatment of Castleman disease so physicians in turn, are equipped to educate, advocate for, and support patients through the diagnosis and treatment process.
Introduction to CD—David C. Fajgenbaum, MD, MBA, MSc
Diagnosis of CD—David C. Fajgenbaum, MD, MBA, MSc
Faculty Panel Discussion: Reflection on Experiences With Diagnosis of CD
Treatment of CD—Sudipto Mukherjee, MD, PhD, MPH
Faculty Panel Discussion: Reflection on Experiences With Treatment of iMCD
Conclusions—Sudipto Mukherjee, MD, PhD, MPH
This activity has been designed to address the educational needs of community and academic physicians specializing in hematology and hematology/oncology. It will also benefit other clinicians who manage patients with Castleman disease (CD).
Click on the link for more information and to register: https://ce.paradigmmc.com/a/EEIITP
Release Date: February 9, 2022
Expiration Date: February 9, 2023
Time to Complete Activity: 1.0 hour